Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Parathyroid Glands00:59

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bacterial specificity of the gut microbiome predicts bone density in primary hyperparathyroidism.

Bone research·2026
Same author

Clinical profile, treatment practices, and complications in chronic hypoparathyroidism in a Middle Eastern cohort.

Journal of the Endocrine Society·2026
Same author

Journal of Bone and Mineral Research (JBMR) 40th anniversary celebration the third decade (part 1).

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026
Same author

Vitamin D in Gut and Systemic Immune Tolerance and in Infections' Risk: An International Evidence-Based Consensus Statement.

Reviews in endocrine & metabolic disorders·2026
Same author

Treatment of hypoparathyroidism (HypoPT): Position Statement of the Expert Group for Polish Society of Endocrinology - update 2026.

Endokrynologia Polska·2026
Same author

Journal of Bone and Mineral Research (JBMR) 40th anniversary celebration: the beginning and first decade.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026
Same journal

Comparison of adenoma and gland hyperplasia on bone mineral density in primary hyperparathyroidism.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry·2026
Same journal

The influence of pregnancy and selected aspects of female health on skeletal status and fracture incidence in postmenopausal women from the RACOST-POL Study.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry·2026
Same journal

The association of sclerostin with osteoporosis and vertebral fractures in patients with type 2 diabetes mellitus.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry·2026
Same journal

Assessment of bone microarchitecture in postmenopausal women with primary hyperparathyroidism using trabecular bone score.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry·2026
Same journal

Erxian decoction for postmenopausal osteoporosis: An updated systematic review and meta-analysis.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry·2026
Same journal

Associations of discordance in hip bone mineral density with hip osteoarthrosis severity and progression to total hip replacement in middle-aged adults.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry·2026
See all related articles

Related Experiment Video

Updated: May 14, 2026

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
07:12

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

Asymptomatic primary hyperparathyroidism.

Shonni J Silverberg1, Marcella D Walker, John P Bilezikian

  • 1Division of Endocrinology, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA. sjs5@columbia.edu

Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
|February 5, 2013
PubMed
Summary
This summary is machine-generated.

Asymptomatic primary hyperparathyroidism (PHPT) is now common, often presenting without clear symptoms. Most patients with this condition do not develop classical signs over time.

More Related Videos

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Related Experiment Videos

Last Updated: May 14, 2026

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
07:12

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Area of Science:

  • Endocrinology
  • Metabolic Disorders

Background:

  • Primary hyperparathyroidism (PHPT) clinical presentation has shifted significantly.
  • The advent of multichannel serum autoanalyzers identified a large cohort with asymptomatic hypercalcemia.

Purpose of the Study:

  • To review data on asymptomatic PHPT.
  • To describe its demographics, natural history, and manifestations.
  • To summarize treatment options for asymptomatic disease.

Main Methods:

  • Selective review of existing data on asymptomatic PHPT.
  • Analysis of demographic, clinical, and biochemical features.
  • Evaluation of skeletal, neuromuscular, psychological, and cardiovascular effects.

Main Results:

  • Asymptomatic PHPT is now the predominant phenotype globally.
  • Most patients with asymptomatic PHPT do not progress to overt symptomatic disease.
  • The review covers various manifestations and treatment considerations.

Conclusions:

  • The clinical landscape of PHPT has evolved towards an asymptomatic presentation.
  • Understanding the natural history and diverse manifestations is crucial.
  • Evidence-based treatment guidelines for asymptomatic PHPT are needed.